Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Since its founding in 1998, Brisbane, Calif.-based Intermune, a startup focused on lung diseases, has exemplified the vagaries of the biotechnology industry.
Spreading the Word On Treating DiseaseAmy Misner letter on Apr 27 article hails Intermune for making medical community aware of idiopathic pulmonary fibrosis and offering drug Actimmune as treatmentMay 11, 2003
It is Roche’s largest acquisition since it purchased the 40% of Genentech it did not already own for $47 billion in 2009.
That study happened only because the FDA rejected Esbriet in 2010 after two previous studies were inconclusive about the drug’s benefit.
About $87 billion in pharmaceutical acquisitions were made in the first half of this year, eclipsing the total for all of 2013, according to Evaluate, a research company.
Drugs Found to Aid Breathing in a Fatal Lung DiseasePatients with idiopathic pulmonary fibrosis who were given pirfenidone or nintedanib declined more slowly, researchers in two studies reported.By Denise GradyMay 18, 2014
Rate how well Intermune lives up to its initial vision.
Do you work at Intermune?
Does Intermune communicate its history to new hires?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| United Therapeutics | 1996 | $2.9B | 950 | 174 |
| Oyster Point Pharma | 2015 | $2.2M | 86 | - |
| Pulmatrix | 2003 | $7.8M | 22 | - |
| Trevi Therapeutics | 2011 | $905.2M | 20 | - |
| PTC Therapeutics | 1998 | $806.8M | 517 | 11 |
| Kura Oncology | 2014 | $53.9M | 121 | 8 |
| Lung Therapeutics | 2013 | $640,000 | 14 | 2 |
| XORTX Therapeutics | - | $6.2B | 2 | - |
| Onspira Therapeutics | 2017 | $410,000 | 30 | - |
| Centocor | 1979 | $110.0M | 3,000 | - |
Zippia gives an in-depth look into the details of Intermune, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Intermune. The employee data is based on information from people who have self-reported their past or current employments at Intermune. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Intermune. The data presented on this page does not represent the view of Intermune and its employees or that of Zippia.
Intermune may also be known as or be related to INTERMUNE INC and Intermune.